JBM  Vol.4 No.10 , October 2016
Association between Toll-Like Receptor 4 (Thr399Ile and Asp299Gly), Toll-Like Receptor 2 196-174 Deletion Polymorphisms with cryptosporidiosis
Abstract: Toll-like receptors (TLRs) 2 and 4 specifically recognize lipopolysaccharide motifs on surfaces of microorganisms. Polymorphims in the TLR genes result in structural variations in the proteins, abnormal host-pathogen interactions and hence, altered immune response. Opportunistic parasite Cryptosporidium spp. infects immuno-compromised patients who present with heterogeneous clinical manifestations ranging from mild infection resolving in a few weeks, to severe form characterized by voluminous diarrhoea, prolonged symptoms and recurrences. The present study investigates the role of TLR2 196_174del, TLR4 Asp299Gly and Thr399Ile polymorphisms in pathogenesis of cryptosporidiosis. Stool samples were collected from 210 immuno-compromised (renal transplant recipients and patients with Human immunodeficiency virus infection) both with and without cryptosporidiosis, and 200 healthy subjects for detection of Cryptosporidium spp. Blood samples were also collected from the patients and healthy subjects for genotyping of Δ22 (TLR2 196_174del) polymorphism, A896G (TLR4 Asp299Gly) and C1196T (Thr399Ile) single nucleotide polymorphisms (SNPs) by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Cryptosporidium spp. was detected in 70 immunocompromised patients, while it was absent in all the healthy controls. No significant difference was observed in Δ22, A896G and C1196T alleles and genotypes (P > 0.05), between cases and controls. Thus, TLR2 196_174del, TLR4 Asp299Gly and Thr399Ile polymorphisms are not significantly associated with the pathogenesis or progression of cryptosporidiosis, in the Indian population included in the study.
Cite this paper: Dey, A. , Ghoshal, U. , Agarwal, V. and Ghoshal, U. (2016) Association between Toll-Like Receptor 4 (Thr399Ile and Asp299Gly), Toll-Like Receptor 2 196-174 Deletion Polymorphisms with cryptosporidiosis. Journal of Biosciences and Medicines, 4, 85-96. doi: 10.4236/jbm.2016.410009.

[1]   Bandin, F., Kwon, T., Linas, M.D., Guigonis, V., Valentin, A., Cassaing, S., Carol, A., Garnier, A., Baudouin, V. and Decramer, S. (2009) Cryptosporidiosis in Paediatric Renal Transplantation. Pediatric Nephrology, 24, 2245-2255.

[2]   Botero, J.H., Castano, A., Montoya, M.N., Ocampo, N.E., Hurtado, M.I. and Lopera, M.M. (2003) A Preliminary Study of the Prevalence of Intestinal Parasites in Immunocompromised Patients with and without Gastrointestinal Manifestations. Revista do Instituto de Medicina Tropical de Sao Paulo, 45, 197-200.

[3]   Nahrevanian, H. and Assmar, M. (2008) Cryptosporidiosis in Immunocompromised Patients in the Islamic Republic of Iran. Journal of Microbiology, Immunology and Infection, 41, 74-77.

[4]   Ok, U.Z., Cirit, M., Uner, A., Ok, E., Akcicek, F., Basci, A. and Ozcel, M.A. (1997) Cryptosporidiosis and Blastocystosis in Renal Transplant Recipients. Nephron, 75, 171-174.

[5]   Udgiri, N., Minz, M., Kashyap, R., Heer, M., Gupta, C.S., Mohandas, K., Minz, R.W. and Malla, N. (2004) Intestinal Cryptosporidiasis in Living Related Renal Transplant Recipients. Transplantation Proceedings, 36, 2128-2129.

[6]   Current, W.L. and Garcia, L.S. (1991) Cryptosporidiosis. Clinical Microbiology Reviews, 4, 325-358.

[7]   Arora, D.R. and Arora, B. (2009) AIDS-Associated Parasitic Diarrhoea. Indian Journal of Medical Microbiology, 27, 185-190.

[8]   Hunter, P.R. and Nichols, G. (2002) Epidemiology and Clinical Features of Cryptosporidium Infection in Immunocompromised Patients. Clinical Microbiology Reviews, 15, 145-154.

[9]   Junpee, A., Tencomnao, T., Sanprasert, V. and Nuchprayoon, S. (2010) Association between Toll-Like Receptor 2 (TLR2) Polymorphisms and Asymptomatic Bancroftian Filariasis. Parasitology Research, 107, 807-816.

[10]   Pandey, S., Mittal, R.D., Srivastava, M., Srivastava, K., Singh, S., Srivastava, S. and Mittal, B. (2009) Impact of Toll-Like Receptors [TLR] 2 (-196 to -174 del) and TLR 4 (Asp299Gly, Thr399Ile) in Cervical Cancer Susceptibility in North Indian Women. Gynecologic Oncology, 114, 501-505.

[11]   Qian, F.H., Zhang, Q., Zhou, L.F., Jin, G.F., Bai, J.L. and Yin, K.S. (2010) Polymorphisms in the Toll-Like Receptor 2 Subfamily and Risk of Asthma: A Case-Control Analysis in a Chinese Population. Journal of Investigational Allergology and Clinical Immunology, 20, 340-346.

[12]   Chen, X.M., O'Hara, S.P., Nelson, J.B., Splinter, P.L., Small, A.J., Tietz, P.S., Limper, A.H. and LaRusso, N.F. (2005) Multiple TLRs Are Expressed in Human Cholangiocytes and Mediate Host Epithelial Defense Responses to Cryptosporidium parvum via Activation of NF-kappaB. Journal of Immunology, 175, 7447-7456.

[13]   O'Hara, S.P., Small, A.J., Gajdos, G.B., Badley, A.D., Chen, X.M. and Larusso, N.F. (2009) HIV-1 Tat Protein Suppresses Cholangiocyte Toll-Like Receptor 4 Expression and Defense against Cryptosporidium parvum. The Journal of Infectious Diseases, 199, 1195-1204.

[14]   Garcia, L.S. (2001) Diagnostic Medical Parasitology. American Society for Microbiology, USA.

[15]   Coupe, S., Sarfati, C., Hamane, S. and Derouin, F. (2005) Detection of Cryptosporidium and Identification to the Species Level by Nested PCR and Restriction Fragment Length Polymorphism. Journal of Clinical Microbiology, 43, 1017-1023.

[16]   Lorenz, E., Frees, K.L. and Schwartz, D.A. (2001) Determination of the TLR4 Genotype Using Allele-Specific PCR. Biotechniques, 31, 22-24.

[17]   Zafra, G., Florez, O., Morillo, C.A., Echeverria, L.E., Martin, J. and Gonzalez, C.I. (2008) Polymorphisms of Toll-Like Receptor 2 and 4 Genes in Chagas Disease. Memórias do Instituto Oswaldo Cruz, 103, 27-30.

[18]   Greene, J.A., Sam-Agudu, N., John, C.C., Opoka, R.O., Zimmerman, P.A. and Kazura, J.W. (2012) Toll-Like Receptor Polymorphisms and Cerebral Malaria: TLR2 Delta22 Polymorphism Is Associated with Protection from Cerebral Malaria in a Case Control Study. Malaria Journal, 11, 47.

[19]   Rasouli, M., Keshavarz, M., Kalani, M., Moravej, A., Kiany, S. and Badiee, P. (2012) Toll-Like Receptor 4 (TLR4) Polymorphisms in Iranian Patients with Visceral Leishmaniasis. Molecular Biology Reports, 39, 10795-10802.

[20]   Verma, A., Prasad, K.N., Gupta, R.K., Singh, A.K., Nyati, K.K., Rizwan, A., Pandey, C.M. and Paliwal, V.K. (2010) Toll-Like Receptor 4 Polymorphism and Its Association with Symptomatic Neurocysticercosis. Journal of Infectious Diseases, 202, 1219-1225.

[21]   Nischalke, H.D., Coenen, M., Berger, C., Aldenhoff, K., Muller, T., Berg, T., Kramer, B., Korner, C., Odenthal, M., Schulze, F., et al. (2012) The Toll-Like Receptor 2 (TLR2)-196 to -174 Del/Ins Polymorphism Affects Viral Loads and Susceptibility to Hepatocellular Carcinoma in Chronic Hepatitis C. International Journal of Cancer, 130, 1470-1475.

[22]   Achyut, B.R., Ghoshal, U.C., Moorchung, N. and Mittal, B. (2007) Association of Toll-Like Receptor-4 (Asp299Gly and Thr399Ileu) Gene Polymorphisms with Gastritis and Precancerous Lesions. Human Immunology, 68, 901-907.

[23]   Tahara, T., Arisawa, T., Wang, F., Shibata, T., Nakamura, M., Sakata, M., Hirata, I. and Nakano, H. (2007) Toll-Like Receptor 2-196 to 174del Polymorphism Influences the Susceptibility of Japanese People to Gastric Cancer. Cancer Science, 98, 1790-1794.